Insomnia News and Research

Latest Insomnia News and Research

Investment report on Somaxon Pharmaceuticals from MicroStockProfit.com

Investment report on Somaxon Pharmaceuticals from MicroStockProfit.com

Labopharm, Gruppo Angelini sign agreement to commercialize OLEPTRO in the U.S.

Labopharm, Gruppo Angelini sign agreement to commercialize OLEPTRO in the U.S.

Neurocrine Biosciences reports net loss of $8.6M in first quarter 2010

Neurocrine Biosciences reports net loss of $8.6M in first quarter 2010

Takeda settles with six defendants in generic ACTOS, ACTOplus met patent infringement lawsuit

Takeda settles with six defendants in generic ACTOS, ACTOplus met patent infringement lawsuit

Takeda announces submission of azilsartan medoxomil NDA for hypertension to FDA

Takeda announces submission of azilsartan medoxomil NDA for hypertension to FDA

Court of Appeals denies McNeil Pediatrics' CONCERTA patent appeal

Court of Appeals denies McNeil Pediatrics' CONCERTA patent appeal

MicroStockProfit.com releases investment report on Rexahn Pharmaceuticals

MicroStockProfit.com releases investment report on Rexahn Pharmaceuticals

Researchers take major step to predict adverse drug reactions using genetic information

Researchers take major step to predict adverse drug reactions using genetic information

Systems biologists integrate new genetic framework to help predict adverse drug reactions

Systems biologists integrate new genetic framework to help predict adverse drug reactions

Homeopathy – Is it a safer and effective alternative?

Homeopathy – Is it a safer and effective alternative?

Racial disparities in sleep and health-related quality of life

Racial disparities in sleep and health-related quality of life

Data from Phase 2 clinical trials of Hematide/peginesatide presented at NKF Annual Meeting

Data from Phase 2 clinical trials of Hematide/peginesatide presented at NKF Annual Meeting

Genzyme presents 4-year follow-up data from Phase 2 MS trial at neurology meeting

Genzyme presents 4-year follow-up data from Phase 2 MS trial at neurology meeting

Patients with RLS using rotigotine achieve sustained improvements

Patients with RLS using rotigotine achieve sustained improvements

Rexahn Pharmaceuticals' Phase IIa clinical results of Serdaxin for MDD: Additional insights

Rexahn Pharmaceuticals' Phase IIa clinical results of Serdaxin for MDD: Additional insights

Phase IIa clinical trial results of Serdaxin for treatment of MDD

Phase IIa clinical trial results of Serdaxin for treatment of MDD

Alkermes submits VIVITROL sNDA for opioid dependence

Alkermes submits VIVITROL sNDA for opioid dependence

Clinical trial data on AMPYRA Extended Release Tablets to be presented at AAN Annual meeting

Clinical trial data on AMPYRA Extended Release Tablets to be presented at AAN Annual meeting

Implanting blue light-filtering IOLs during cataract surgery may help preserve retina health

Implanting blue light-filtering IOLs during cataract surgery may help preserve retina health

New tool for retrieving accurate drug side-effect information

New tool for retrieving accurate drug side-effect information

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.